These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19326961)

  • 21. Etanercept for refractory asthma therapy.
    Antoniu SA
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1279-81. PubMed ID: 16989602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab for asthma.
    Strunk RC; Bloomberg GR
    N Engl J Med; 2006 Jun; 354(25):2689-95. PubMed ID: 16790701
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging therapeutic strategies for asthma management.
    Sullivan SD; Meltzer EO
    J Manag Care Pharm; 2003; 9(5 Suppl):14-21. PubMed ID: 14613436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biotherapies for the treatment of asthma: are they the treatment of the future?].
    Tonnel AB; Denis G; Lelong J
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S44-10S48. PubMed ID: 17127963
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-IgE for chronic asthma in adults and children.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003559. PubMed ID: 16625585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti IgE antibodies for the treatment of difficult asthma].
    Humbert M; Tonnel AB
    Rev Mal Respir; 2005 Dec; 22(6 Pt 1):983-90. PubMed ID: 16222222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-tNFalpha therapy in chronic severe asthma].
    Tomasiak MM; Zietkowski Z; Tomasiak M; Skiepko R; Bodzenta-Lukaszyk A
    Pol Arch Med Wewn; 2006 Oct; 116(4):998-1004. PubMed ID: 18416303
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
    Busse WW; Morgan WJ; Gergen PJ; Mitchell HE; Gern JE; Liu AH; Gruchalla RS; Kattan M; Teach SJ; Pongracic JA; Chmiel JF; Steinbach SF; Calatroni A; Togias A; Thompson KM; Szefler SJ; Sorkness CA
    N Engl J Med; 2011 Mar; 364(11):1005-15. PubMed ID: 21410369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-IgE for chronic asthma.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003559. PubMed ID: 12917972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-IgE for chronic asthma in adults and children.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting TNF-alpha: a novel therapeutic approach for asthma.
    Brightling C; Berry M; Amrani Y
    J Allergy Clin Immunol; 2008 Jan; 121(1):5-10; quiz 11-2. PubMed ID: 18036647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basophil activation test: do not lose control.
    Maietta G
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):36-7. PubMed ID: 25781191
    [No Abstract]   [Full Text] [Related]  

  • 33. Predicting and evaluating response to omalizumab in patients with severe allergic asthma.
    Bousquet J; Rabe K; Humbert M; Chung KF; Berger W; Fox H; Ayre G; Chen H; Thomas K; Blogg M; Holgate S
    Respir Med; 2007 Jul; 101(7):1483-92. PubMed ID: 17339107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements.
    Hamilton RG
    J Allergy Clin Immunol Pract; 2016; 4(2):366-8. PubMed ID: 26968963
    [No Abstract]   [Full Text] [Related]  

  • 35. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).
    Graves JE; Nunley K; Heffernan MP
    J Am Acad Dermatol; 2007 Jan; 56(1):e55-79. PubMed ID: 17190618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
    Casale TB;
    Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-IgE for asthma in inner-city children.
    Geraci C; Longo G
    N Engl J Med; 2011 Jun; 364(26):2557; author reply 2557-8. PubMed ID: 21714663
    [No Abstract]   [Full Text] [Related]  

  • 38. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
    Solèr M; Matz J; Townley R; Buhl R; O'Brien J; Fox H; Thirlwell J; Gupta N; Della Cioppa G
    Eur Respir J; 2001 Aug; 18(2):254-61. PubMed ID: 11529281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of refractory asthma with antibodies].
    Lommatzsch M
    Dtsch Med Wochenschr; 2016 Jun; 141(11):790-3. PubMed ID: 27254629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of EPR3 asthma guidelines: what's different?
    Lang DM
    Allergy Asthma Proc; 2007; 28(6):620-7. PubMed ID: 18201424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.